Table 5.
Characteristics | Reference or source | |
---|---|---|
Strain | ||
E. coli | ||
HB101 | F–supE44 hsdS20(r-Bm-B) recA13 ara-14 proA2 lacY1 galK2 rpsL20 xyl-5 mtl-1 | |
DH5α | F– Φ80lacZΔM15 Δ(lacZYA-argF) U169 recA1 endA1 hsdR17 (rK–, mK+) phoA supE44 λ– thi-1 gyrA96 relA1 | |
C. difficile | ||
JIR8094 | EmS derivative of strain 630 | (O’Connor et al., 2006) |
LB-CD8 | JIR8094 prdR::ermB | (Bouillaut et al., 2013) |
LB-CD24 | JIR8094 rex::ermB | This study |
ND-CD23 | JIR8094 rex::ermB Tn916::rex | This study |
B. subtilis | ||
BS49 | (Manganelli et al., 1998) | |
Plasmid | ||
pBL26 | pSMB47 containing catP | This study |
pBL64 | pCR2.1-intron template part A | (Bouillaut et al., 2013) |
pBL65 | pCR2.1-intron template part B | (Bouillaut et al., 2013) |
pBL100 | pBL68 containing un-targeted groupII intron – Targetron vector | (Bouillaut et al., 2013) |
pBL130 | pBL100 targeted to rex | This study |
pCR2.1 | Invitrogen® | |
pND1 | pBL26 containing rex gene with its own promoter | This study |
pRK24 | Tra+, Mob+, AmpR, TcR | (Trieu-Cuot et al., 1991) |
pSMB47 | (Manganelli et al., 1998) |